.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Baxter
Mallinckrodt
Fuji
Cipla
Deloitte
Chubb
Chinese Patent Office
Teva

Generated: November 24, 2017

DrugPatentWatch Database Preview

Meropenem - Generic Drug Details

« Back to Dashboard

What are the generic sources for meropenem and what is the scope of meropenem freedom to operate?

Meropenem
is the generic ingredient in four branded drugs marketed by Sandoz, Acs Dobfar, Pfizer, B Braun Medical Inc, Aurobindo Pharma Ltd, Par Sterile Products, Hospira Inc, Gland Pharma Ltd, Daewoong Pharm Co, Amneal Pharms, Savior Lifetec Corp, and Rempex Pharms Medcns, and is included in twelve NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for meropenem. Fourteen suppliers are listed for this compound.

Pharmacology for meropenem

Ingredient-typeCarbapenems
Drug ClassPenem Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rempex Pharms Medcns
VABOMERE
meropenem; vaborbactam
POWDER;IV (INFUSION)209776-001Aug 29, 2017RXYesYes► Subscribe► SubscribeYY ► Subscribe
B Braun Medical Inc
MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
meropenem
POWDER;IV (INFUSION)202106-002Apr 30, 2015RXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
MEROPENEM
meropenem
INJECTABLE;INJECTION205835-001Mar 27, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Par Sterile Products
MEROPENEM
meropenem
INJECTABLE;INJECTION204139-002Jun 9, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
MEROPENEM
meropenem
INJECTABLE;INJECTION090940-002Jun 22, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
Acs Dobfar
MEROPENEM
meropenem
INJECTABLE;INJECTION091404-002Oct 26, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
MEROPENEM
meropenem
INJECTABLE;INJECTION205883-001Apr 12, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Savior Lifetec Corp
MEROPENEM
meropenem
INJECTABLE;INJECTION206086-001Apr 19, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Gland Pharma Ltd
MEROPENEM
meropenem
INJECTABLE;INJECTION206141-001Jun 8, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Pfizer
MERREM
meropenem
INJECTABLE;INJECTION050706-001Jun 21, 1996APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: meropenem

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
MERREM
meropenem
INJECTABLE;INJECTION050706-001Jun 21, 1996► Subscribe► Subscribe
Pfizer
MERREM
meropenem
INJECTABLE;INJECTION050706-003Jun 21, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Teva
Harvard Business School
Healthtrust
Argus Health
Julphar
Fuji
Colorcon
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot